secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2023-02-17T23:59:59+00:00
Accession:  0000950170-23-003125
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q4 GAAP EPS $0.29, adjusted $0.47; revenue $514M; 2023 EBITDA guidance $235-245M
--------------------------------------------------------------------------------

- Net revenue $513.8M (+3.1% YoY); same-unit patient volume +4.1%; commercial payor mix improved 20 bps.
- GAAP diluted EPS $0.29 vs $0.47; Adjusted EPS $0.47 vs $0.52; CARES Act benefit declined materially.
- Adjusted EBITDA $66.5M vs $81.0M; full year 2022 Adjusted EBITDA $241.0M, GAAP EPS $0.74.
- 2023 preliminary Adjusted EBITDA guidance $235-245M, assuming no additional CARES Act funds.
- Revenue cycle management vendor underperformance partly offset by vendor support; overhead costs reduced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017023003125/0000950170-23-003125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017023003125/md-20230217.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-003125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer